NCT07146282View on ClinicalTrials.gov

Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status

Not yet recruitingOBSERVATIONAL

Enrollment

165

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

October 31, 2027

Conditions

Rheumatic Heart Disease

All Listed Sponsors

lead

Ahmed Hassan Rostom Ibrahim

OTHER

NCT07146282 - Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status | Biotech Hunter | Biotech Hunter